Skip to main content
AAN.com
Clinical/Scientific Notes
March 8, 2004

Interferon-β treatment decreases cholesterol plasma levels in multiple sclerosis patients

First page of PDF

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Rosenzweig IB, Wiebe DA, Borden EC, Storer B, Shrago ES. Plasma lipoprotein changes in humans induced by beta-interferon. Atherosclerosis. 1987; 67: 261–267.
2.
Byskosh PV, Reder AT. Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis. Mult Scler. 1996; 1: 262–269.
3.
Andrade RJ, Garcia-Escano MD, Valdivielso P, et al. Effects of interferon-beta on plasma lipid and lipoprotein composition and post-heparin lipase activities in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2000; 14: 929–935.
4.
Dixon RM, Borden EC, Keim NL, et al. Decreases in serum high-density-lipoprotein cholesterol and total cholesterol resulting from naturally produced and recombinant DNA-derived leukocyte interferons. Metabolism. 1984; 33: 400–404.
5.
Naeem M, Bacon BR, Mistry B, Britton RS, Di Bisceglie AM. Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C. Am J Gastroenterol. 2001; 96: 2468–2472.
6.
Sena A, Pedrosa R, Ferret-Sena V, et al. Interferon beta1a therapy changes lipoprotein metabolism in patients with multiple sclerosis. Clin Chem Lab Med. 2000; 38: 209–213.
7.
Giubilei F, Antonini G, Di Legge S, et al. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol Scand. 2002; 106: 109–112.

Information & Authors

Information

Published In

Neurology®
Volume 62Number 5March 9, 2004
Pages: 829-830
PubMed: 15007146

Publication History

Received: June 16, 2003
Accepted: October 28, 2003
Published online: March 8, 2004
Published in print: March 9, 2004

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

V. Brescia Morra, MD
From the Department of Neurological Sciences, Federico II University, Naples, Italy.
G. Coppola, MD
From the Department of Neurological Sciences, Federico II University, Naples, Italy.
G. Orefice, MD
From the Department of Neurological Sciences, Federico II University, Naples, Italy.
G. De Michele, MD
From the Department of Neurological Sciences, Federico II University, Naples, Italy.
G. Vacca, MD
From the Department of Neurological Sciences, Federico II University, Naples, Italy.
A. Filla, MD
From the Department of Neurological Sciences, Federico II University, Naples, Italy.
V. Bonavita, MD
From the Department of Neurological Sciences, Federico II University, Naples, Italy.

Notes

Address correspondence and reprint requests to Dr. Vincenzo Brescia Morra, Dipartimento di Scienze Neurologiche, Università Federico II, Via Pansini 5, I-80131 Napoli, Italy; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis, Neurology Neuroimmunology & Neuroinflammation, 9, 3, (2022)./doi/10.1212/NXI.0000000000001165
    Abstract
  2. Stroke risk in multiple sclerosis: a critical appraisal of the literature, International Journal of Neuroscience, 133, 10, (1132-1152), (2022).https://doi.org/10.1080/00207454.2022.2056459
    Crossref
  3. Local cholesterol metabolism orchestrates remyelination, Trends in Neurosciences, 45, 4, (272-283), (2022).https://doi.org/10.1016/j.tins.2022.01.001
    Crossref
  4. Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity, Proceedings of the National Academy of Sciences, 118, 1, (2020).https://doi.org/10.1073/pnas.2018457118
    Crossref
  5. High density lipoprotein cholesterol and apolipoprotein A-I are associated with greater cerebral perfusion in multiple sclerosis, Journal of the Neurological Sciences, 418, (117120), (2020).https://doi.org/10.1016/j.jns.2020.117120
    Crossref
  6. Multiple sclerosis and stroke: a systematic review and meta-analysis, BMC Neurology, 19, 1, (2019).https://doi.org/10.1186/s12883-019-1366-7
    Crossref
  7. Type-I interferons in atherosclerosis, Journal of Experimental Medicine, 217, 1, (2019).https://doi.org/10.1084/jem.20190459
    Crossref
  8. High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus?, Journal of Clinical Lipidology, 13, 4, (654-663.e1), (2019).https://doi.org/10.1016/j.jacl.2019.06.003
    Crossref
  9. Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients, Journal of Lipid Research, 58, 2, (403-411), (2017).https://doi.org/10.1194/jlr.M072751
    Crossref
  10. Dietary cholesterol promotes repair of demyelinated lesions in the adult brain, Nature Communications, 8, 1, (2017).https://doi.org/10.1038/ncomms14241
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share